MAUDE Adverse Event Report: ETHICON INC. INTERCEED* (TC7); BARRIER, ABSORBABLE, ADHESION

Catalog Number 4350

Device Problem Adverse Event Without Identified Device or Use Problem (2993)

Patient Problems Abscess (1690); Pain (1994)

Event Type  Injury  

Manufacturer Narrative

(b)(4).To date the device has not been returned.If the device or further details are received at the later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: the patient demographic info: age, gender, weight, bmi at the time of index procedure? unknown.Date of index surgical procedure? unknown.Product lot number? unknown.The diagnosis and indication for the index surgical procedure? distal gastrectomy.Was there a culture taken? results? unknown.How was it confirmed to be an abscess? blood and ct examination.Does the surgeon believe there was any alleged deficiency with the device that contributed to the reported adverse event? the surgeon commented that the possible cause is a foreign body reaction by the interceed, because the drainage of fluid was more brown than usual, an abscess occurred at the site where the interceed was applied, and there were also diabetes.What is the patient current status? the patient has been discharged currently.No further information will be provided.

Event Description

It was reported that the patient underwent a distal gastrectomy procedure on unknown date and the absorbable adhesive barrier was placed between the liver and the stomach before closing the wound.Five to seven days after surgery, pain occurred in the upper abdomen and blood test and ct examination showed an abscess formation where the absorbable adhesive barrier was placed.The abscess was removed by performing drainage for about 2 weeks.Antibiotics were administered in addition to drainage as a treatment.Currently, there is no problem with the patient and no additional treatment is planned.The surgeon opines that the possible cause is a foreign body reaction by the absorbable adhesive barrier, because the drainage of fluid was more brown than usual, an abscess occurred at the site where the device was applied.It was also reported that the patient had also diabetes and it is thought that abscess was due to the patient¿s immunity decline.Hospitalization was extended for about two weeks.The patient is currently discharged.No further information is available.

• Type of Device: BARRIER, ABSORBABLE, ADHESION
• Manufacturer (Section D): ETHICON INC.; p.o. box 151, route 22 west; somerville NJ 08876 0151
• Manufacturer (Section G): ETHICON INC.-SAN LORENZO PR; 982 road 183 km 8.3; san lorenzo PR
• Manufacturer Contact: darlene kyle ; p.o. box 151, route 22 west; somerville, NJ 08876-0151 ; 9082182792
• MDR Report Key: 8507321
• MDR Text Key: 141730631
• Report Number: 2210968-2019-80303
• Device Sequence Number: 1
• Product Code: MCN
• UDI-Device Identifier: 10705031005396
• UDI-Public: 10705031005396
• Combination Product (y/n): N
• PMA/PMN Number: P880047
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: company representative,foreig
• Reporter Occupation: Other
• Type of Report: Initial
• Report Date: 03/15/2019

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 04/11/2019
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Catalogue Number: 4350
• Was Device Available for Evaluation?: No
• Date Manufacturer Received: 03/15/2019
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Is the Device Single Use?: Yes
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Hospitalization; Required Intervention